NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InsiderHannah Alison L.
This page shows the track record and history of HANNAH ALISON L. insider trades in NeoGenomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Hannah Alison L. in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-07-27 20,000 9.1900 20,000 9.1900 183,800 348 14.25 101,200 55.06
2016-03-03 10,000 6.9000 10,000 6.9000 69,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Hannah Alison L. in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-06-03 2025-06-01 4 HANNAH ALISON L. NEO Common Stock A - Award D 12,254 131,023
2025-06-03 2025-06-01 4/A HANNAH ALISON L. NEO Common Stock M - Exercise D 12,254 131,023
2024-08-13 2024-08-10 4 HANNAH ALISON L. NEO Common Stock M - Exercise D 11,336 118,769
2022-06-14 2022-06-10 4 HANNAH ALISON L. NEO Common Stock A - Award D 15,556 107,433
2021-06-04 2021-06-02 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) A - Award D 40.90 3,714 3,714
2021-06-04 2021-06-02 4 HANNAH ALISON L. NEO Common Stock A - Award D 3,081 91,877
2020-08-10 2020-08-06 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) M - Exercise D 7.27 -10,000 0
2020-08-10 2020-08-06 4 HANNAH ALISON L. NEO Common Stock M - Exercise D 7.2700 10,000 73 88,796
2020-06-01 2020-05-28 4 HANNAH ALISON L. NEO Stock Options (Right to Buy) A - Award D 28.54 3,448 3,448
2020-06-01 2020-05-28 4 HANNAH ALISON L. NEO Common Stock A - Award D 2,698 78,796
2019-09-11 2019-09-09 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) M - Exercise D 9.11 9.1100 -8,333 -76 0
2019-09-11 2019-09-09 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) M - Exercise D 6.66 6.6600 -3,333 -22 0
2019-09-11 2019-09-09 4 HANNAH ALISON L. NEO Common Stock M - Exercise D 9.1100 8,333 76 76,098
2019-09-11 2019-09-09 4 HANNAH ALISON L. NEO Common Stock M - Exercise D 6.6600 3,333 22 67,765
2019-06-10 2019-06-06 4 HANNAH ALISON L. NEO Stock Options (Right to Buy) A - Award D 22.52 4,269 4,269
2019-06-10 2019-06-06 4 HANNAH ALISON L. NEO Common Stock A - Award D 3,419 64,432
2018-06-05 2018-06-01 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) A - Award D 11.60 3,017 3,017
2018-06-05 2018-06-01 4 HANNAH ALISON L. NEO Common Stock A - Award D 15,564 61,013
2017-10-03 2017-08-09 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) X - Other D 6.66 6.6600 -6,667 -44 3,333
2017-10-03 2017-08-09 4 HANNAH ALISON L. NEO Common Stock M - Exercise D 6.6600 6,667 44 45,449
2017-07-31 2017-07-27 4 HANNAH ALISON L. NEO Common Stock P - Purchase D 9.1900 20,000 184 38,782
2017-05-30 2017-05-30 4 HANNAH ALISON L. NEO Restricted Stock C - Conversion D -5,072 0
2017-05-30 2017-05-30 4 HANNAH ALISON L. NEO Restricted Stock C - Conversion D -2,150 0
2017-05-30 2017-05-30 4 HANNAH ALISON L. NEO Common Stock M - Exercise D 7,222 18,782
2017-05-30 2017-05-25 4 HANNAH ALISON L. NEO Restricted Stock A - Award D 8,667 8,667
2017-05-30 2017-05-25 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) A - Award D 7.27 7.2700 10,000 73 10,000
2016-08-01 2016-07-28 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) A - Award D 9.11 9.1100 8,333 76 25,555
2016-08-01 2016-07-28 4 HANNAH ALISON L. NEO Restricted Stock A - Award D 5,072 7,222
2016-05-04 2016-04-20 4 HANNAH ALISON L. NEO Common Stock A - Award D 7.1500 2,150 15 13,710
2016-03-04 2016-03-03 4 HANNAH ALISON L. NEO Common stock P - Purchase D 6.9000 10,000 69 11,560
2015-07-16 2015-07-15 4 HANNAH ALISON L. NEO Stock Option (Right to Buy) A - Award D 6.66 6.6600 10,000 67 10,000
2015-06-19 3 HANNAH ALISON L. NEO Common Stock D 3,120
2015-06-19 3 HANNAH ALISON L. NEO Common Stock D 3,120
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)